Diversify Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.7M Buy
64,821
+60,566
+1,423% +$13M 0.28% 72
2026
Q1
$868K Sell
4,255
-26,171
-86% -$5.81M 0.13% 76
2025
Q4
$6.52M Sell
30,426
-400
-1% -$91.1K 0.21% 80
2025
Q3
$6.53M Buy
30,826
+50
+0.2% +$10.2K 0.22% 76
2025
Q2
$6.11M Buy
30,776
+10,883
+55% +$2.02M 0.23% 71
2025
Q1
$3.85M Buy
19,893
+1,788
+10% +$348K 0.24% 71
2024
Q4
$3.17M Sell
18,105
-6,472
-26% -$1.19M 0.17% 83
2024
Q3
$4.64M Sell
24,577
-4,212
-15% -$786K 0.25% 79
2024
Q2
$4.84M Sell
28,789
-5,591
-16% -$926K 0.27% 70
2024
Q1
$6.21M Buy
+34,380
New +$5.93M 0.37% 59

Other funds holding ABBV

Diversify Advisory Services's ABBV Position: Q2 2026 in Review

Diversify Advisory Services increased its AbbVie (ABBV) stake by 1,423% in Q2 2026, buying an estimated $13M and bringing the position to 64,821 shares worth $16.7M. The position accounts for 0.28% of the portfolio, ranked #72.

Diversify Advisory Services first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Diversify Advisory Services held 64,821 shares of AbbVie worth $16.7M as of Q2 2026.
  • Diversify Advisory Services bought 60,566 AbbVie shares in Q2 2026, an estimated $13M.
  • AbbVie made up 0.28% of Diversify Advisory Services's portfolio in Q2 2026, its #72 holding.
  • Diversify Advisory Services first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.